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The incidence and outcome of epilepsy in tuberous sclerosis (TS) patients have not yet 
been thoroughly investigated. The aim of this study was to evaluate the clinical features 
and prognosis of epileptic seizures associated with TS. The medical records of 29 patients 
who satisfied the diagnostic criteria for TS and were followed up for at least 2 years at 
the Department of Pediatrics, Chonnam National University Hospital (CNUH), between 
January 2000 and December 2010 were reviewed. Onset age of seizure, initial electro-
encephalography (EEG) findings, and efficacy of treatment were evaluated. Brain imag-
ing studies were reanalyzed to determine the number of cortical tubers and sub-
ependymal nodules present. A total of 26 (89.6%) cases presented with seizures. In the 
seizure-controlled group (n=9, 34.6%), the mean number of cortical tubers was 4.5 (range, 
0-16) and the mean number of subependymal nodules was 6.2 (range, 0-14). Initial EEG 
identified epileptiform discharges in 4 (44.5%) of these cases. In the seizure-sustained 
group (n=17, 58.6%), 10 patients had initial seizures before 1 year of age. In this group, 
the mean number of cortical tubers was 6.0 (range, 0-20) and the mean number of sub-
ependymal nodules was 6.0 (range, 1-11). A total of 15 (88.2%) had epileptiform dis-
charges on their initial EEGs. In three patients who did not show any seizures during 
the observation period, the mean number of cortical tubers was 1.3 (range, 0-2), and the 
mean number of subependymal nodules was 4.6 (range, 0-13). Medical intractability of 
epilepsy in conjunction with TS did not correlate with age at onset of seizure, the number 
of cortical tubers, or subependymal nodules, but was associated with initial EEG findings.
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INTRODUCTION
Tuberous sclerosis (TS), which was first described by 
Bourneville in 1,880, is an autosomal dominant inherited 
neurocutaneous syndrome. The presence of TS genes on 
chromosomes 9 and 16 was recently revealed.
1 The disease 
prevalence is 1 in 6,000, and the disease involves various 
organs forming hamartomas in the central nervous system 
(CNS), skin, eyes, heart, and lungs.
2
In the case of CNS invasion, neurological symptoms such 
as epileptic seizures or mental retardation can be shown. 
Epileptic seizure, mental retardation, and facial angiofi-
broma are known as a clinical triad, but in two thirds of pa-
tients, these symptoms may not appear.
3 Among those 
symptoms, epileptic seizure is a major factor determining 
quality of life in the affected children. Various types of epi-
leptic seizure are reported in patients with TS, including 
infantile spasms;
4,5 furthermore, the onset age or the se-
verity of the seizures also varies in each patient. Even in 
cases with infantile spasms, the individual seizure out-
comes vary and are strongly affected by the development 
of new antiepileptic agents, including vigabatrin. Several 
studies have been published about seizure or epilepsy out-
comes in TS patients with infantile spasms after the in-
troduction of new antiepileptic drugs.
6,7 However, these 
studies were mainly focused on the seizures that developed 
during the infantile period. The epileptic seizures in chil-
dren with TS have not been fully described. 
In this study, we investigated initial clinical features in-
cluding brain imaging studies and electroencephalograms 151
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FIG. 1. Age and sex distribution of patients.
TABLE 1. Clinical characteristics of seizure-controlled and seizure-free patients
Patient No./ 
sex
Age at diagnosis
(months)
Onset of 1st seizure
(months)
1st seizure 
type
Onset of seizure-controlled 
state (months)
Follow-up 
duration
1st EEG 
finding
1/M
2/F
3/M
4/F
5/M
6/F
7/F
8/F
9/M
10/M
11/M
12/M
120
96
3
48
9
10
9
60
3
168
120
60
120
96
3
48
9
10
9
60
4
GTC
CP
IS
T
IS
T
IS
GTC
GTC
96
132
60
96
24
24
24
120
1
72
24
132
24
96
108
72
1
23
48
36
24
Focal slowing
Focal slowing
Hypsarrhythmia
Diffuse slowing
Diffuse slowing
Focal spikes
Hypsarrhythmia
Diffuse slowing
Diffuse slowing
EEG: electroencephalography, GTC: generalized tonic clonic, CP: complex partial, IS: infantile spasm, T: tonic.
in children with TS to determine possible prognostic pre-
dictors of epilepsy in TS. 
MATERIALS AND METHODS
Among 35 patients (20 male, 15 female) who were diag-
nosed as having TS by the criteria of Roach
7 in the pediatric 
clinic of Chonnam National University Hospital (CNUH) 
from January 2000 to December 2010, 29 patients (16 male, 
13 female) who were followed up for at least 2 years were the 
focus of this study. For each patient, age at diagnosis, pres-
ence of epileptic seizure, period of first seizure attack, initial 
electroencephalography (EEG), type of initial seizure, ini-
tial brain computed tomography (CT), initial brain magnetic 
resonance imaging (MRI), treatment, and prognosis were 
retrospectively reviewed. Initial EEG was analyzed as back-
ground activity, presence, and distribution of epileptiform 
discharge, whereas brain images were analyzed as the num-
ber of cortical tubers and subependymal nodules. In analyz-
ing the data, we looked for correlations between the results 
and control of epileptic seizures. Types of epileptic seizures 
were sorted as infantile spasm, generalized tonic clonic type, 
tonic type, atonic type, and partial complex type. Also, an-
ti-epileptic medication used to treat seizures during the fol-
low-up period was reviewed. For patients whose epileptic 
seizures were controlled, onset of the seizure-controlled 
state was reviewed. The patients were classified into three 
groups by the presence and control of epileptic seizures as 
follows: the group without epileptic seizures, the seiz-
ure-controlled group, and the seizure-sustained group. 
SPSS software (version 18.0, SPSS Inc, Chicago, IL, USA) 
was used for the statistical analysis, and p-values less than 
0.05 were considered to be significant.
RESULTS
1. Clinical features
The mean follow-up period of the 29 patients who had 
been followed up for longer than 2 years was 99.6 months 
(range, 24-208 months). Among them, male patients were 
predominant; there were 16 (55%) males and 13 (45%) fe-
males, and the mean age at diagnosis was 51.6 months 
(range, 10 days to 168 months). Fifteen (51.7%) children 
were diagnosed before 1 year of age, the youngest one on 
10 days after birth (Fig. 1). Three (10.3%) did not show any 
seizure during the follow-up period but mainly skin lesions; 
the mean age at diagnosis of this group was 114 months 
(range, 60-168 months). The mean follow-up period was 36 
months (range, 24-48 months) (Table 1).
2. Outcome of seizures
Twenty-six of 29 patients showed epileptic seizures dur-
ing the follow-up period. Infantile spasm was the most com-
mon type of seizure, occurring in 12 (46%) cases, followed 
by generalized tonic clonic (n=8, 30.7%), tonic (n=3, 11.5%), 
complex partial (n=2, 7.6%), and atonic (n=1, 3.8%) seizure. 
Three patients showed epileptic seizure 40 days after being 
diagnosed as having TS, and 2 of them visited the hospital 
because of skin lesions and 1 for cardiac rhabdomyoma be-
fore 1 year of age. Two of them showed infantile spasms and 
1 showed generalized tonic clonic seizure. 152
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TABLE 2. Clinical characteristics of seizure-sustained patients
Patient No./ 
sex
Age at diagnosis 
(months)
Onset of 1st 
seizure (months)
1st seizure 
type
Follow-up 
duration (months)
1st EEG findings
Brain lesions
Cortical 
tuber
Subependymal 
nodule
13/M
14/F
15/M
16/F
17/F
18/M
19/M
20/M
21/F
22/M
23/F
24/M
25/F
26/M
27/F
28/F
29/M
10
36
96
5
7
36
48
3
60
120
10 days
108
4
1
6
9
4
10
36
96
5
7
36
48
3
60
120
10 days
108
4
3
7
9
4
IS
GTC
GTC
IS
IS
AT
GTC
IS
CP
T
IS
GTC
IS
IS
IS
GTC
IS
84
72
204
72
120
168
156
120
120
144
132
24
36
60
60
60
24
Hypsarrhythmia
Focal spikes
Generalized spikes
Hypsarrhythmia
Hypsarrhythmia
Generalized spikes
Focal slowing
Hypsarrhythmia
Focal spikes
Focal spikes
Hypsarrhythmia
Focal spikes
Hypsarrhythmia
Hypsarrhythmia
Hypsarrhythmia
Focal spikes
Hypsarrhythmia
8
0
0
13
1
4
2
5
4
20
5
0
15
1
6
2
14
1
2
5
7
9
9
4
9
9
11
10
0
5
4
7
2
9
EEG: electroencephalography, IS: infantile spasm, GTC: generalized tonic clonic, AT: atonic, CP: complex partial, T: tonic.
TABLE 3. Initial characteristics of patients with seizures and outcome
Seizure controlled (n=9), No. (%) Seizure sustained (n=17), No. (%) p value
Age at 1st seizure
    ≤1 y
    ＞1 y
1st seizure type
    Infantile spasm
    Other seizures*
1st EEG 
    Epileptiform discharge
    Non-epileptiform discharge
5 (55.6)
4 (44.4)
3 (33.4)
6 (66.6)
5 (55.5)
4 (44.5)
10 (58.8)
7 (41.2)
9 (52.9)
8 (47.1)
15 (88.3)
2 (11.7)
0.85
0.34
0.04
*Other seizures: generalized tonic clonic, complex partial, tonic, atonic. EEG: electroencephalography.
Among 26 patients, seizure was controlled in 9 (34.6%) 
cases and the mean duration before seizures were con-
trolled was 64 months (range, 1-132 months). The mean du-
ration of the seizure-free state was 61 months (range, 1-151 
months) (Fig. 1, Table 1). In the other 17 (65.4%) cases, seiz-
ures were not controlled with multiple anti-epileptic medi-
cations during the follow-up period (mean, 97.41 months; 
duration, 24-204 months).
3. Ages of seizure onset
The first epileptic seizure was shown before 1 year of age 
in 15 cases, 10 (66.6%) of which were resistant to multiple 
anti-epileptic medications. Of 11 cases in which the first 
seizure was shown after 1 year of age, 7 (63.6%) were intrac-
table. There was no definite correlation between the age of 
seizure onset and the outcome of seizure in TS (p=0.85). 
4. Type of initial seizure
In the analysis of first seizure type and prognosis of epi-
leptic seizure in patients with TS, 3 (25.0%) of 12 patients 
with infantile spasms as their first seizure experienced 
control of seizures, whereas 6 (42.8%) of 14 patients with 
other seizure types showed improvement of seizures, 
which stood for a better prognosis (p=0.34) (Table 2).
5. Initial EEG findings
Fifteen (75%) of 20 patients who showed epileptiform 
discharges in their initial EEGs had sustained seizure, 
whereas 4 (66.7%) of 6 who showed non-epileptiform abnor-
malities had a good outcome. Initial EEG finding and seiz-
ure outcome had a positive correlation (p=0.04) (Table 3).
6. Brain images
Neuroimaging examinations were performed in all 29 
patients (22 MRI, 7 CT). The counted mean number of corti-
cal tubers was 4.9 (range, 0-20) and that of subependymal 
nodules was 5.6 (range, 0-14). The mean number of cortical 
tubers in patients without epilepsy (n=3) was 1.3±1.1 153
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FIG. 2. Duration of seizure-free state.
TABLE 4. Mean number of brain lesions in each group of TS patients
Number of cortical tubers,
mean±SD (range)
Number of subependymal nodules, 
mean±SD (range)
p value
No seizure group (n=3)
Seizure-free group (n=9)
Seizure-sustained group (n=17)
1.3±1.1 (0-2)
4.5±5.0 (0-20)
6.0±5.9 (0-2)
4.6±5.5 (0-13)
6.2±5.0 (1-11)
6.0±3.6 (0-9)
0.21
0.35
0.89
TS: tuberous sclerosis.
(range, 0-2), that in the seizure-controlled group (n=9) was 
4.5±5.0 (range, 0-20), and that in the seizure-sustained 
group (n=17) was 6.0±5.9 (range, 0-2). No definite correla-
tion between number of brain lesions and outcome of seiz-
ure was noted (p=0.9) (Table 4). 
In 2 patients, astrocytoma was shown. In one, seizure 
was sustained and in the other it was controlled during the 
follow-up period. In the total 21 patients examined by MRI, 
6 patients showed abnormal white matter; epileptic seiz-
ures in 3 of them were sustained and seizures in the other 
3 patients were controlled.
Both MRI and CT were performed in 6 cases; one of them 
did not show cortical tubers in the CT image, whereas MRI 
revealed one cortical tuber. In the other 5 cases, there were 
no differences in brain lesions between the images.
7. Anti-epileptic medications
The mean number of applied anti-epileptic medications 
was 3.1 (range, 1-6), including vigabatrin. In the seizure- 
controlled group (n=9), the mean number of drugs was 2 
(range, 0-3), and all of the patients in this group took vig-
abatrin initially. Only 1 of them, however, improved with 
vigabatrin only. Four of them improved with topiramate, 
2 with oxcarbazepine, and 1 with carbamazepine and lamo-
trigine (Table 1). In the seizure-sustained group (n=17), the 
mean number of applied drugs was 3.8 (range, 2-6). In the 
cases of infantile spasm (n=12), ACTH was applied in 3 
(25.0%) and only 1 (33.3%) showed a seizure-control effect.
 DISCUSSION
Because TS has been reported to have high frequency of 
neurological manifestations, such as epileptic seizure or 
mental retardation, evaluations and treatment of them are 
important. Epileptic seizure in children with TS is related 
to refractory seizure that is not responsive to multidrug 
treatment.
5 Most TS patients (more than 90%) have seiz-
ure at least once, and 75% of them show their seizure before 
1 year of age.
7 In this study, a first seizure before 1 year of 
age was observed in 15 (57.6%) patients, which is relatively 
lower than in other reports.
6 Infantile spasm was diag-
nosed in 12 cases (80.0%), which were the most frequent 
seizure type.
5 Seizure was controlled in only 3 (25.0%) of 
the 12 patients, which was a lower ratio than that of the 
whole patient group (n=7/26, 34.0%). ACTH treatment was 
applied to 3 patients among them, and only one (33.3%) 
showed a seizure-control effect. Infantile spasms are a com-
mon symptom of TS that are present in one-third to two- 
thirds of cases.
4 Features of infantile spasm are cluster 
seizure, which shows repeated spasms at short intervals 
and hypsarrhythmia on EEG.
4 Pampigline reported that 
20% of infantile spasms are caused by TS.
8 Because in-
fantile spasm itself is a risk factor for causing mental re-
tardation,
4,9 prompt diagnosis and control of seizure is 
important. In this study of TS, the rate of infantile spasm 
was also high, and it tends to become refractory.
According to the report of Kim and Hwang,
6 complex par-
tial seizure is related to poor prognosis because it tends to 
remain refractory after childhood. But in this study, in-
fantile spasm tended to be refractory, although it was not 
statistically significant. Only two cases of complex partial 
seizure were present in this study, one in the seizure-con-
trolled group and the other in the sustained group. 
Epileptic seizure in TS patients can occur at any time of 
life but is generally known to be exacerbated during pu-
berty.
8 In this study, 3 (patients 1, 2, and 8) of 9 patients 
whose seizures were controlled later showed seizure activi-
ties during the pubertal period; the other 6 showed activity 
at a preadolescent age (Fig. 2). Thus, continuous observa-
tion is needed.
Some studies have reported normal findings on neuro-
imaging examinations in patients with TS at an early 
age.
1,10 In this study, MRI revealed many cortical tubers 
and subependymal nodules suitable for diagnosis of TS 
even in a 1-month-old infant with seizure at 10 days after 154
Clinical Progress of Epilepsy in Children with Tuberous Sclerosis
birth.
Ninety percent of periventricular and subependymal ha-
martomas are accompanied by calcification and are easily 
observed by CT, and a positive correlation between degree 
of calcification in cortical tubers and severity of epileptic 
seizure has been reported.
11-13 Epileptogenicity may also be 
related to the tuber itself because of a mass effect on sur-
rounding tissue or vascular abnormalities.
Moreover, other studies have reported that the number 
and location of cortical tubers detected by MRI is closely re-
lated to the severity of epileptic seizure.
14,15 In this study, 
more brain lesions were detected in the seizure-sustained 
group than in the seizure-controlled or seizure-free group, 
but the difference was not statistically significant (p=0.54). 
Although there was no strong positive correlation between 
the number of brain lesions and seizure outcomes, these re-
sults do not definitively indicate that there is no relation 
between the size or location of brain lesions and epi-
leptogenicity itself, because there a case was reported in 
which surgical removal of cortical tubers improved seizure 
outcome.
11
Even a subtle abnormal white matter lesion could be de-
tected by MRI, and six or more abnormal findings in a pa-
tient are highly related to mental retardation.
14 In this 
study of 6 cases, all of them were mentally retarded and had 
epilepsy; 3 (50%) of them were refractory. 
In addition, previous studies reported that seizure-in-
ducing cortical tubers could be differentiated by positron 
emission tomography (PET).
16,17 However, PET was not 
performed in this study.
In the seizure-sustained group, the incidence of epilepti-
form discharges in the initial EEG recordings was higher 
(n=15/17, 88.2%) than in the seizure-controlled group (n= 
5/9, 55.5%). This result suggests that initial EEG abnor-
mality may be related to incurableness. 
The mean number of applications of anti-epileptic medi-
cations in TS patients was higher in the seizure-sustained 
group (3.8±1.2) than in the seizure-controlled group (2± 
0.9). However, a direct comparison was impossible because 
of a shortage of patients and various combinations of the 
drugs. Control of an epileptic seizure by additional top-
iramate, however, was observed in 4 of 9 cases, which sug-
gested the efficacy of secondary medication other than vig-
abatrin in controlling epileptic seizures.
18
To conclude, the correlation between the outcome of epi-
lepsy and the initial clinical findings, including age of on-
set, first seizure type, and brain imaging findings, was not 
strong compared with that for initial EEG findings. 
Further extended study of the progression of epilepsy and 
other clinical features of TS might be required. 
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